|
| Status |
Public on Aug 01, 2015 |
| Title |
Reversal of microRNA-150 silencing disadvantages crizotinib-resistant NPM-ALK-positive cell growth. |
| Organism |
Homo sapiens |
| Experiment type |
Methylation profiling by high throughput sequencing
|
| Summary |
We used bisulfite conversion and Illumina sequencing to analyse miR-150 DNA methylation pattern lost in cells treated with decitabine, a demethylating agent, Crizotinib, an inhibitor of of ALK activity or siALK
|
| |
|
| Overall design |
Targeted bisulfite conversion and Illumina sequencing in two cell lines bearing the t(2;5)(p23;q35)
|
| |
|
| Contributor(s) |
Meggetto F, Hoareau-Aveilla C |
| Citation missing |
Has this study been published? Please login to update or notify GEO. |
| Submission date |
Jun 12, 2015 |
| Last update date |
May 15, 2019 |
| Contact name |
Coralie Hoareau-Aveilla |
| Organization name |
INSERM
|
| Department |
CRCT
|
| Street address |
2 avenue Hubert Curien
|
| City |
toulouse |
| ZIP/Postal code |
31037 |
| Country |
France |
| |
|
| Platforms (1) |
| GPL18573 |
Illumina NextSeq 500 (Homo sapiens) |
|
| Samples (6)
|
|
| Relations |
| BioProject |
PRJNA286887 |
| SRA |
SRP059443 |
Less...
More...